Последние новости от компании Др. Фальк Фарма
Добро пожаловать на нашу страницу новостей, где предоставлены последние новости, пресс-релизы, аннонсы клинических исследований, информация о мероприятиях и многое другое от компании Др. Фальк Фарма.
Burden of disease of Primary Sclerosing Cholangitis
A Retrospective Cohort Study in Germany
Dr. Falk Pharma acquires Kynos Therapeutics
...adding acute pancreatitis as a therapeutic focus and further strengthening its development portfolio
Following the footsteps of our founder
Herbert Falk's granddaughter Elena decided to follow her grandpa's footsteps. Why? Find out more and follow Elena on her journey.
EASL 2024
From 5-8 June 2024 in Milan - we look forward to seeing you (exhibition space E2)
FDA clearance of IND application for naronapride
...to treat gastroparesis and subsequent expansion of ongoing phase 2b study to the US
Advancing the development of naronapride...
...for patients with PPI-non-responsive symptomatic GERD as the second naronapride indication